NGM120, a GFRAL Antagonist Antibody, for Investigation of Safety, Tolerability and Efficacy in Hyperemesis Gravidarum presented by Joanne Lancaster, PhD at the International Colloquium of Hyperemesis Gravidarum (ICHG) 2024 conference in Ventura, California.